Search Results - "Wagener, M. E."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Integrin Antagonists Prevent Costimulatory Blockade‐Resistant Transplant Rejection by CD8+ Memory T Cells by Kitchens, W. H., Haridas, D., Wagener, M. E., Song, M., Kirk, A. D., Larsen, C. P., Ford, M. L.

    Published in American journal of transplantation (01-01-2012)
    “…The success of belatacept in late‐stage clinical trials inaugurates the arrival of a new class of immunosuppressants based on costimulatory blockade, an…”
    Get full text
    Journal Article
  2. 2

    An Anti‐CD154 Domain Antibody Prolongs Graft Survival and Induces Foxp3+ iTreg in the Absence and Presence of CTLA‐4 Ig by Pinelli, D. F., Wagener, M. E., Liu, D., Yamniuk, A., Tamura, J., Grant, S., Larsen, C. P., Suri, A., Nadler, S. G., Ford, M. L.

    Published in American journal of transplantation (01-11-2013)
    “…The use of monoclonal antibodies targeting the CD154 molecule remains one of the most effective means of promoting graft tolerance in animal models, but…”
    Get full text
    Journal Article
  3. 3

    Pathogen Stimulation History Impacts Donor‐Specific CD8+ T Cell Susceptibility to Costimulation/Integrin Blockade–Based Therapy by Badell, I. R., Kitchens, W. H., Wagener, M. E., Lukacher, A. E., Larsen, C. P., Ford, M. L.

    Published in American journal of transplantation (01-12-2015)
    “…Recent studies have shown that the quantity of donor‐reactive memory T cells is an important factor in determining the relative heterologous immunity barrier…”
    Get full text
    Journal Article
  4. 4

    Rapamycin ameliorates the CTLA4‐Ig–mediated defect in CD8+ T cell immunity during gammaherpesvirus infection by Pinelli, D. F., Wakeman, B. S., Wagener, M. E., Speck, S. H., Ford, M. L.

    Published in American journal of transplantation (01-10-2015)
    “…Latent viral infections are a major concern among immunosuppressed transplant patients. During clinical trials with belatacept, a CTLA4‐Ig fusion protein,…”
    Get full text
    Journal Article
  5. 5

    Selective CD28 Blockade Results in Superior Inhibition of Donor‐Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4‐Ig by Badell, I. R., La Muraglia, G. M., Liu, D., Wagener, M. E., Ding, G., Ford, M. L.

    Published in American journal of transplantation (01-01-2018)
    “…Donor‐specific antibodies (DSAs) are a barrier to improved long‐term outcomes after kidney transplantation. Costimulation blockade with CTLA4‐Ig has shown…”
    Get full text
    Journal Article
  6. 6

    Antigenic Disparity Impacts Outcome of Agonism but Not Blockade of Costimulatory Pathways in Experimental Transplant Models by Ford, M. L., Wagener, M. E., Gangappa, S., Pearson, T. C., Larsen, C. P.

    Published in American journal of transplantation (01-06-2007)
    “…Treatment regimens consisting of CTLA‐4 Ig/anti‐CD154 or agonistic anti‐CD28/rapamycin have both been shown to prevent GVHD in fully allogeneic murine model…”
    Get full text
    Journal Article
  7. 7

    Failure to Induce Neonatal Tolerance in Mice That Lack Both IL-4 and IL-13 but Not in Those That Lack IL-4 Alone by Inoue, Yoshihiko, Konieczny, Bogumila T, Wagener, Maylene E, McKenzie, Andrew N. J, Lakkis, Fadi G

    Published in The Journal of immunology (1950) (15-07-2001)
    “…Current evidence suggests that neonatal tolerance to a foreign Ag is the consequence of IL-4-mediated Th2 immunity rather than the thymic deletion of…”
    Get full text
    Journal Article
  8. 8

    Alloantigen-driven T cell death mediated by fas ligand and tumor necrosis factor-α is not essential for the induction of allograft acceptance by WAGENER, M. E, KONIECZNY, B. T, ZHENHUA DAI, RING, G. H, LAKKIS, F. G

    Published in Transplantation (15-06-2000)
    “…Fas ligand (FasL)-Fas and tumor necrosis factor alpha (TNFalpha)-tumor necrosis factor receptor (TNFR) interactions regulate immune responses and contribute to…”
    Get full text
    Journal Article
  9. 9

    Emery-Dreifuss muscular dystrophy by Zacharias, A S, Wagener, M E, Warren, S T, Hopkins, L C

    Published in Seminars in neurology (1999)
    “…Emery-Dreifuss muscular dystrophy (EDMD) is the third most common X-linked muscular dystrophy. This disorder is characterized by childhood onset of early…”
    Get more information
    Journal Article
  10. 10

    Selective CD28 blockade results in superior inhibition of donor-specific T follicular helper cell and antibody responses relative to CTLA-4-Ig by Badell, IR, La Muraglia, GM, Liu, D, Wagener, ME, Ding, G, Ford, ML

    Published in American journal of transplantation (14-08-2017)
    “…Donor-specific antibodies (DSA) are a barrier to improved long-term outcomes following kidney transplantation. Costimulation blockade with CTLA-4-Ig has shown…”
    Get full text
    Journal Article
  11. 11

    Combined Costimulatory and Leukocyte Functional Antigen-1 Blockade Prevents Transplant Rejection Mediated by Heterologous Immune Memory Alloresponses by KITCHENS, William H, HARIDAS, Divya, WAGENER, Maylene E, MINGQING SONG, FORD, Mandy L

    Published in Transplantation (27-05-2012)
    “…Recent evidence suggests that alloreactive memory T cells are generated by the process of heterologous immunity, whereby memory T cells arising in response to…”
    Get full text
    Journal Article
  12. 12

    High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade by Floyd, Tamara L, Orr, Steven B, Coley, Shana M, Hanna, Samantha S, Wagener, Maylene E, Kirk, Allan D, Larsen, Christian P, Ford, Mandy L

    Published in Transplantation (27-05-2010)
    “…Blockade of costimulatory molecules is a potent method of inducing long-term graft survival. We have previously addressed the issue of donor-reactive T-cell…”
    Get full text
    Journal Article